Auburndale, Massachusetts, United States The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Auburndale.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2015. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the 20/20 HealthCare Partners, startups are often financed by MassChallenge, Maine Angels. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, Highlight Capital, Alexandria Venture Investments. In the next rounds fund is usually obtained by Quark Venture, Polaris Partners, NanoDimension.
Among the most successful fund investment fields, there are Therapeutics, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight SQZ Biotech. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
Funds with similar focus
| Fund Name | Location |
| 10Pearls Ventures | - |
| Accelero Capital | France, Ile-de-France, Paris |
| Africa Internet Holding | Lagos, Lagos, Nigeria |
| Aryt Industries | - |
| Associated Bank | Green Bay, United States, Wisconsin |
| CorLyst, LLC | Ellicott City, Maryland, United States |
| Dragonvest Partners | China, Shanghai |
| Gameloft | Barcelona, Catalonia, Spain |
| Hermitage Equity Partners | Nashville, Tennessee, United States |
| insprout | Chiyoda, Japan |
| Kagra Gruppen AS | - |
| Montpelier Foundation | England, London, United Kingdom |
| Orange Silicon Valley | California, San Francisco, United States |
| Prepaid Technologies | Alabama, Birmingham, United States |
| Sciencons | - |
| Struck Capital Crypto | California, Santa Monica, United States |
| Stundi | Phuket, Phuket Province, Thailand |
| Yiqu Wangluo | China, Zhejiang, Zhuji |
| Youdu Qiye Guanli Zixun | China, Tianjin, Wuqing |
| ZTC Private Markets GmbH | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Variantyx | $41M | 14 Feb 2022 | Framingham, Massachusetts, United States | ||
Variantyx | $20M | 15 Mar 2021 | Framingham, Massachusetts, United States | ||
EnClear Therapies | $10M | 19 Feb 2020 | Cambridge, Massachusetts, United States | ||
| $5M | 24 Jun 2015 | Massachusetts, United States | |||
QBotix | $6M | 04 Sep 2012 | California, United States |
– Variantyx, a Boston, MA-based hereditary disease testing company, secured $20M in Series C funding.
– The round was led by GHS Fund (Quark Venture LP and GF Securities) and includes new investor, IBM Ventures and current investors, Pitango Venture Capital, New Era Capital Partners, 20/20 HealthCare Partners.
– In conjunction with the funding, Zafrira Avnur, PhD, Quark Venture Chief Scientific Officer & Partner, will join the Variantyx board of directors.
– The company intends to use the funds for development of its tumor diagnostic solutions and the expansion of sales.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Variantyx | $41M | 14 Feb 2022 | Framingham, Massachusetts, United States | ||
Variantyx | $20M | 15 Mar 2021 | Framingham, Massachusetts, United States | ||
EnClear Therapies | $10M | 19 Feb 2020 | Cambridge, Massachusetts, United States | ||
| $5M | 24 Jun 2015 | Massachusetts, United States | |||
QBotix | $6M | 04 Sep 2012 | California, United States |
